AR002274A1 - Composicion farmaceutica para administracion topica, producto farmaceutico que la contiene, y metodos para la manufactura de medicamentos que la contienen - Google Patents

Composicion farmaceutica para administracion topica, producto farmaceutico que la contiene, y metodos para la manufactura de medicamentos que la contienen

Info

Publication number
AR002274A1
AR002274A1 ARP960101278A AR10127896A AR002274A1 AR 002274 A1 AR002274 A1 AR 002274A1 AR P960101278 A ARP960101278 A AR P960101278A AR 10127896 A AR10127896 A AR 10127896A AR 002274 A1 AR002274 A1 AR 002274A1
Authority
AR
Argentina
Prior art keywords
composition
manufacture
pharmaceutical composition
methods
pharmaceutical
Prior art date
Application number
ARP960101278A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of AR002274A1 publication Critical patent/AR002274A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Una composición farmacéutica para administración tópica que comprende una combinación de foscarnet y un glucocorticoide antiinflamatorio en mezcla conun portador a base de galactolípidos y un solvente polar. La composición farmacéutica puedeusarse en el tratamiento profiláctico y/o curativo deinfecciones por herpesvirus en mamíferos, incluyendo al hombre, especialmente por HSV-1, HSV-2 y VZV, en la piel, las membranas mucosas o los ojos. Dichacomposición es particularmente útil en eltratamiento de infecciones por herpesvirus recurrentes. Esta composición es también útil en todas aquellasinfecciones causadas por otros virus en las cuales resulta eficaz el foscarnet. Además, se da a conocer un producto farmacéutico en forma de crema, loción,gel, ungüento, parche, barra o lápiz, que contiene a dicha composición y métodos para la manufactura de medicamentos que contienen a dicha composición.
ARP960101278A 1995-02-06 1996-02-05 Composicion farmaceutica para administracion topica, producto farmaceutico que la contiene, y metodos para la manufactura de medicamentos que la contienen AR002274A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9500112 1995-02-06

Publications (1)

Publication Number Publication Date
AR002274A1 true AR002274A1 (es) 1998-03-11

Family

ID=20396817

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960101278A AR002274A1 (es) 1995-02-06 1996-02-05 Composicion farmaceutica para administracion topica, producto farmaceutico que la contiene, y metodos para la manufactura de medicamentos que la contienen

Country Status (18)

Country Link
US (1) US6068860A (es)
EP (1) EP0809501A1 (es)
JP (1) JPH11509515A (es)
KR (1) KR19980701958A (es)
AR (1) AR002274A1 (es)
AU (1) AU715212B2 (es)
CA (1) CA2211409A1 (es)
DZ (1) DZ1965A1 (es)
FI (1) FI973230A0 (es)
HR (1) HRP960033A2 (es)
IL (1) IL116910A0 (es)
MA (1) MA23799A1 (es)
NO (1) NO973611L (es)
NZ (1) NZ301406A (es)
TN (1) TNSN96023A1 (es)
WO (1) WO1996024359A1 (es)
YU (1) YU7196A (es)
ZA (1) ZA96526B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438585B (en) * 1995-02-06 2001-06-07 Astra Ab Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
FR2814071A1 (fr) * 2000-09-21 2002-03-22 Oreal Composition a base de glycoglyceride et ses utilisations notamment cosmetiques
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
CN104117066B (zh) * 2014-07-16 2016-03-02 陈凌 外敷用抗甲状腺软膏的制备方法
US10759163B2 (en) 2014-10-27 2020-09-01 Hewlett-Packard Development Company, L.P. Printing device

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009842B1 (en) * 1978-10-02 1982-11-10 THE PROCTER & GAMBLE COMPANY Liposomes for drug delivery and composition containing a liposome drug system
US4512978A (en) * 1980-01-24 1985-04-23 Inwood Louis R Dermatological composition useful in the treatment of psoriasis
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
ES2036593T3 (es) * 1986-06-12 1993-06-01 The Liposome Company, Inc. Composiciones que utilizan medicamentos antiinflamatorios no esteroidales encapsulados en liposomas.
WO1989005152A1 (en) * 1987-12-09 1989-06-15 The Regents Of The University Of California Liposome-encapsulated anti-viral composition and method
US5227165A (en) * 1989-11-13 1993-07-13 Nova Pharmaceutical Corporation Liposphere delivery systems for local anesthetics
GB9315755D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized formulation

Also Published As

Publication number Publication date
NO973611D0 (no) 1997-08-05
KR19980701958A (ko) 1998-06-25
YU7196A (sh) 1998-09-18
AU4682096A (en) 1996-08-27
TNSN96023A1 (fr) 2005-03-15
AU715212B2 (en) 2000-01-20
FI973230A (fi) 1997-08-05
MA23799A1 (fr) 1996-10-01
DZ1965A1 (fr) 2002-07-17
IL116910A0 (en) 1996-09-12
EP0809501A1 (en) 1997-12-03
FI973230A0 (fi) 1997-08-05
CA2211409A1 (en) 1996-08-15
NO973611L (no) 1997-09-26
NZ301406A (en) 1999-01-28
JPH11509515A (ja) 1999-08-24
WO1996024359A1 (en) 1996-08-15
ZA96526B (en) 1996-08-06
HRP960033A2 (en) 1997-10-31
US6068860A (en) 2000-05-30

Similar Documents

Publication Publication Date Title
AR002030A1 (es) Composiciones farmaceuticas para administracion a la piel o a las mucosas, y uso de una combinacion de aciclovir e hidrocortisona para la elaboracion de medicamentos
US7399790B2 (en) Virucidal compositions
BRPI0112962B8 (pt) composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos
ES2075011T3 (es) Uso de sales del acido gamma-hidroxibutirico para preparar composiciones farmaceuticas para uso en el tratamiento del alcoholismo, y las composiciones obtenidas.
CA2293470A1 (en) Benzimidazole derivatives
ES2172670T3 (es) Pirrolpirimidinas y procedimientos para su preparacion.
HUP0202311A2 (hu) Aeroszollá alakított fertőzésgátló, gyulladásgátló és vértolulást gátló szerek az orrmelléküreg-gyulladás kezelésében
ES2150050T3 (es) Polisacaridos injertados con antioxidantes y su utilizacion.
MY106242A (en) Pharmaceutical composition for the prevention of sexually transmitted diseases.
AR015933A1 (es) Esmalte para unas con actividad antipsoriasica y procedimiento para su preparacion
MX9603596A (es) Perfluoropolieteres o composiciones de los mismos para prevencion y tratamiento de infecciones virales topicas.
AR002274A1 (es) Composicion farmaceutica para administracion topica, producto farmaceutico que la contiene, y metodos para la manufactura de medicamentos que la contienen
ES2188995T3 (es) Uso de un inhibidor de la h+, k+-atpasa en el tratamiento de los polipos nasales.
ES2145360T3 (es) Sales cristalinas y estables de acido tetrahidrofolico.
BR9810711A (pt) Formulação tópica de pulverização antipruriginosa, e, processo para prevenção ou tratamento de prurido em um paciente
CA2439413C (en) Virucidal compositions
AU2002251933A1 (en) Virucidal compositions
BR0008192A (pt) Emplastros tipo folha
SE9200199L (sv) Farmaceutisk komposition och dess anvaendning
AR002957A1 (es) Una combinacion de compuestos utiles, su uso para preparar un medicamento, y una composicion y combinacion farmaceutica que los contienen.
AU3354997A (en) Topical composition containing amino acid in combination with either interferon or thymidine derivatives for treating viral or inflammation diseases
ES2128353T3 (es) Composicion topica que contiene penciclovir.
ES2175661T3 (es) Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
MX9303985A (es) Nucleosidos terapeuticos.
WO1996001633A1 (es) Nueva formulacion para el tratamiento topico de la psoriasis